Cargando…
In vivo Bioluminescence Imaging Used to Monitor Disease Activity and Therapeutic Response in a Mouse Model of Tauopathy
Many studies of tauopathy use transgenic mice that overexpress the P301S mutant form of tau. Neuronal damage in these mice is associated with astrogliosis and induction of glial fibrillary acidic protein (GFAP) expression. GFAP-luc transgenic mice express firefly luciferase under the GFAP promoter,...
Autores principales: | Dunn-Meynell, Ambrose A., Dowling, Peter, Marchese, Michelle, Rodriguez, Esther, Blumberg, Benjamin, Choi, Yun-Beom, Gaindh, Deeya, Lu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751306/ https://www.ncbi.nlm.nih.gov/pubmed/31572168 http://dx.doi.org/10.3389/fnagi.2019.00252 |
Ejemplares similares
-
Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy
por: Choi, Yun-Beom, et al.
Publicado: (2021) -
Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAE
por: Gaindh, Deeya, et al.
Publicado: (2020) -
Monitoring the Response of Hyperbilirubinemia in the Mouse Brain by In Vivo Bioluminescence Imaging
por: Manni, Isabella, et al.
Publicado: (2016) -
Application of Bioluminescence Imaging for In Vivo Monitoring of Fungal Infections
por: Brock, Matthias
Publicado: (2012) -
Triple Bioluminescence Imaging for In Vivo Monitoring of Cellular Processes
por: Maguire, Casey A, et al.
Publicado: (2013)